Daria holds a Master’s and PhD in Clinical Epidemiology and a post-doctoral fellowship in pharmacoeconomics. Dr. O’Reilly became an Associate Professor, Department of Health Research Methods, Evidence and Impact, McMaster University in 2007 and continues to hold a part-time appointment. Over the past two decades, Daria has worked in the area of Health Technology Assessment for the government and the pharmaceutical industry to develop evidence to support informed healthcare policy decision making. She has authored two book chapters and more than 100 scientific papers. Daria joined the TELUS Health team September 2018 as Lead Health Economist. Her priority is reviewing the economic evidence of drugs submitted for formulary listing, ensuring the results are relevant to the private payer, and providing recommendations to help make evidence-informed reimbursement decisions based on cost effectiveness.
Agenda: Day 1 Oct 5, 2020
PANEL DISCUSSION: PRIVATE PAYERS’ PERSPECTIVE
Pathways to Access & Reimbursement for Private Payers
Learn about important processes being used to gain drug listing and understand how the private payer market in Canada is evolving.
Agenda: Day 2 Oct 6, 2020